Syndax Pharmaceuticals, Inc.【SNDX】 営業キャッシュフローの推移
機能の使い方
|
（単位：千ドル）
|
営業キャッシュフロー
|
前年比（％）
|
|
4Q25
|
-69,488
|
+21.1%
|
|
3Q25
|
-70,535
|
+13.2%
|
|
2Q25
|
-87,795
|
+22.5%
|
|
1Q25
|
-95,162
|
+13.9%
|
|
4Q24
|
-57,388
|
+38.8%
|
|
3Q24
|
-62,322
|
+39.6%
|
|
2Q24
|
-71,645
|
+102.6%
|
|
1Q24
|
-83,548
|
+113.0%
|
|
4Q23
|
-41,349
|
+80.6%
|
|
3Q23
|
-44,653
|
+56.4%
|
|
2Q23
|
-35,371
|
-12.2%
|
|
1Q23
|
-39,228
|
-6.4%
|
|
4Q22
|
-22,894
|
-122.7%
|
|
3Q22
|
-28,544
|
+14.4%
|
|
2Q22
|
-40,306
|
+67.6%
|
|
1Q22
|
-41,931
|
+85.6%
|
|
4Q21
|
100,709
|
-744.3%
|
|
3Q21
|
-24,944
|
+36.3%
|
|
2Q21
|
-24,045
|
+12.3%
|
|
1Q21
|
-22,589
|
+41.8%
|
|
4Q20
|
-15,631
|
+22.8%
|
|
3Q20
|
-18,297
|
+114.5%
|
|
2Q20
|
-21,407
|
+70.9%
|
|
1Q20
|
-15,925
|
-5.4%
|
|
4Q19
|
-12,727
|
-15.4%
|
|
3Q19
|
-8,529
|
-53.8%
|
|
2Q19
|
-12,525
|
-
|
|
1Q19
|
-16,831
|
-15.3%
|
|
4Q18
|
-15,043
|
+18.2%
|
|
3Q18
|
-18,469
|
+81.4%
|
|
1Q18
|
-19,870
|
+56.9%
|
|
4Q17
|
-12,722
|
+22.1%
|
|
3Q17
|
-10,181
|
-11.1%
|
|
2Q17
|
-11,800
|
+71.3%
|
|
1Q17
|
-12,668
|
+97.8%
|
|
4Q16
|
-10,416
|
-
|
|
3Q16
|
-11,448
|
-
|
|
2Q16
|
-6,890
|
-
|
|
1Q16
|
-6,403
|
-
|